Genor Biopharma Holdings Limited

DB:67N0 Stock Report

Market Cap: €66.5m

Genor Biopharma Holdings Management

Management criteria checks 2/4

Genor Biopharma Holdings' CEO is Feng Guo, appointed in Apr 2020, has a tenure of 4.25 years. total yearly compensation is CN¥24.29M, comprised of 18.5% salary and 81.5% bonuses, including company stock and options. directly owns 1.15% of the company’s shares, worth €767.42K. The average tenure of the management team and the board of directors is 3.9 years and 2.6 years respectively.

Key information

Feng Guo

Chief executive officer

CN¥24.3m

Total compensation

CEO salary percentage18.5%
CEO tenure4.3yrs
CEO ownership1.2%
Management average tenure3.9yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Feng Guo's remuneration changed compared to Genor Biopharma Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥24mCN¥5m

-CN¥674m

Sep 30 2023n/an/a

-CN¥637m

Jun 30 2023n/an/a

-CN¥599m

Mar 31 2023n/an/a

-CN¥665m

Dec 31 2022CN¥32mCN¥5m

-CN¥730m

Sep 30 2022n/an/a

-CN¥800m

Jun 30 2022n/an/a

-CN¥870m

Mar 31 2022n/an/a

-CN¥868m

Dec 31 2021CN¥41mCN¥5m

-CN¥865m

Compensation vs Market: Feng's total compensation ($USD3.34M) is above average for companies of similar size in the German market ($USD525.52K).

Compensation vs Earnings: Feng's compensation has been consistent with company performance over the past year.


CEO

Feng Guo (54 yo)

4.3yrs

Tenure

CN¥24,285,000

Compensation

Dr. Feng Guo Ph D., serves as Chairman of the Board for Genor BioPharma Co., Ltd. since November 2021.He serves as Chairman at Genor Biopharma Holdings Limited since November 02, 2021. Dr. Guo has been th...


Leadership Team

NamePositionTenureCompensationOwnership
Feng Guo
CEO & Chairman4.3yrsCN¥24.29m1.15%
CN¥ 767.4k
Chengyi Weng
Vice President of Financeno datano datano data
Qibin Liang
Chief Technology Officer2.8yrsno datano data
Shuhua Han
Chief Scientist3.5yrsno datano data
Xiaojing Zhu
Vice President of Compliance & Administrationno datano datano data
Tong Li
Chief Medical Officer3.9yrsno datano data
Tak Wai Ip
Company Secretary2.1yrsno datano data
Jun Lin
Vice President of Quality Analysis4.5yrsno datano data
Qingtang Duan
General Manager of Yuxi Genor4.9yrsno datano data

3.9yrs

Average Tenure

54.5yo

Average Age

Experienced Management: 67N0's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Feng Guo
CEO & Chairman4.3yrsCN¥24.29m1.15%
CN¥ 767.4k
David J. Kerr
Member of Scientific Advisory Board2.6yrsno datano data
Leonard B. Saltz
Member of Scientific Advisory Board2.6yrsno datano data
Wen Chen
Independent Non-Executive Director4.1yrsCN¥420.00kno data
Alex A. Adjei
Member of Scientific Advisory Board2.6yrsno datano data
Edwin Fung
Independent Non-Executive Director4.1yrsCN¥420.00kno data
Honghao Zhou
Independent Non-Executive Director3.8yrsCN¥420.00kno data
Dong Lyu
Non Executive Director2.7yrsno datano data
Zhijian Chen
Chairman of Scientific Advisory Board3.2yrsno datano data
Yangxin Fu
Member of Scientific Advisory Board2.6yrsno datano data
John F. Seymour
Member of Scientific Advisory Board2.6yrsno datano data
John R. Zalcberg
Member of Scientific Advisory Board2.6yrsno datano data

2.6yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 67N0's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.